Skip to main content
. 2023 Oct 27;30(10):2233–2244. doi: 10.1158/1078-0432.CCR-22-3573

Figure 6.

Figure 6. PFS in patients with and without acquired ESR1 alterations in MONARCH 3 (A) and nextMONARCH (B). CI, confidence interval; HR, hazard ratio.

PFS in patients with and without acquired ESR1 alterations in MONARCH 3 (A) and nextMONARCH (B). CI, confidence interval; HR, hazard ratio.